A New York City abortion business plans to profit off women’s desperation by selling more abortion drugs if the U.S. Supreme Court overturns Roe v. Wade this summer.
Danco Laboratories, the primary producer of the abortion drug Mifeprex in the U.S., told ABC News this week that it is prepared to meet an anticipated increased demand. Mifeprex, or mifepristone, is used to kill unborn babies up to 10 weeks of pregnancy by blocking the pregnancy-sustaining hormone progesterone.
“We are prepared for any surge,” a spokesperson for the New York City abortion business told the news outlet. “Our supply is stable and plentiful.”
The end of Roe appears likely, and both pro-life and pro-abortion activists acknowledge that pro-life laws do stop abortions and save lives. However, the push to expand abortion drugs is a growing problem and a dangerous one that puts mothers and their unborn babies in jeopardy.
Pro-life advocates are concerned that the abortion drugs will be sold or smuggled in illegally to states that ban abortions once Roe is overturned. Unlike with surgical abortions, abortion drugs are easier to hide, and “a doctor would not necessarily be able to tell if the woman took the drug or if she miscarried unless she told them,” according to ABC News.
Last year, the Biden administration also began allowing abortion drugs to be sold through the mail without any direct medical supervision, despite the increased risks to women. The change made it even easier for pregnant mothers or their abusers to obtain the drugs to abort unborn babies.
Get the latest pro-life news and information on Twitter. Follow @LifeNewsHQ
Now, Danco wants the Biden administration to expand the abortion drugs even more by requiring pharmacies to provide them.
Here’s more from the report:
[Mifeprex is] currently not available through U.S. pharmacies, although Danco Laboratories says it’s working with the Food and Drug Administration so that pharmacies would be allowed to carry the drug by year’s end.
The FDA allows the drug to be prescribed through a telehealth appointment and mailed to her home. However, at least 19 states have enacted laws requiring that the clinician be present physically when administering the drug.
The Danco spokesperson refused to provide additional details about their company, describing it only as “modestly profitable and [saying] it no longer needs to rely on private investors as it had early on in its tenure. The company declined to release annual production estimates,” according to ABC News.
These private investors included some of the richest men in the world: Warren Buffett, George Soros and the Packard family, according to a 2001 U.S. Congressional report.
A recent analysis from Live Action News found that abortion drugs are especially lucrative, with sales nearing $300 million per year in the United States.
Mifepristone now is used for more than half of all abortions in the U.S., the Guttmacher Institute reported in February. In 2020, the drug was responsible for 54 percent of all unborn babies’ abortion deaths, up from 39 percent in 2017, the pro-abortion research group found.
Abortion drugs are dangerous and can be deadly for the mother as well as her unborn baby. In the United States, the FDA has linked mifepristone to at least 26 women’s deaths and 4,000 serious complications between 2000 and 2018. However, under President Barack Obama, the FDA stopped requiring that non-fatal complications from mifepristone be reported. So the numbers almost certainly are much higher.
A study, published in December in the journal “Health Services Research and Managerial Epidemiology,” found a “significant” gap in reports on abortion complications from mifepristone.
Another 2021 study by the Charlotte Lozier Institute found that the rate of abortion-related emergency room visits by women taking the abortion drug increased more than 500 percent between 2002 and 2015. And a 2009 study “Immediate Complications After Medical Compared With Surgical Termination of Pregnancy,” in “Obstetrics and Gynecology” found a complication rate of approximately 20 percent for the abortion drugs compared to 5.6 percent for surgical abortions. Hemorrhages and incomplete abortions were among the most common complications.
Pro-life advocates also have raised concerns about mail-order abortion businesses making it easier for abusers and sex traffickers to force their victims to abort their unborn babies. Studies show a strong link between coercion, abuse and abortion, and without an in-person visit, it is even more difficult for abortionists to screen women for abuse.
